| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $530,294 ) |
| 2024 | 2024 | THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Biology Research | 000 | 4 | 7/1/2024 | NON-COMPETING CONTINUATION | $530,294 |
|
| Issue Date FY: 2023 ( Subtotal = $467,592 ) |
| 2023 | 2023 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Biology Research | 000 | 3 | 6/21/2023 | NON-COMPETING CONTINUATION | $467,592 |
|
| Issue Date FY: 2022 ( Subtotal = $425,258 ) |
| 2022 | 2022 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Biology Research | 000 | 2 | 6/30/2022 | NON-COMPETING CONTINUATION | $425,258 |
|
| Issue Date FY: 2021 ( Subtotal = $433,936 ) |
| 2021 | 2021 | UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD UNIT 207 | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Biology Research | 000 | 1 | 6/29/2021 | NEW | $433,936 |
|
|